PartsTable TECHNICAL DATA SHEET
NSN 6505-01-387-1892Government record, cited

Gabapentin Capsules6505-01-387-1892

NSN 6505-01-387-1892 · NIIN 013871892 · Part number NDC50228-0179-01
Sciegen Pharmaceuticals Inc · FSC 6505 — Drugs and Biologicals · FSG 65 — Medical, Dental, and Veterinary Equipment · CAGE 8NLP1
Government record, cited
NSN 6505-01-387-1892 — this item is cataloged by the U.S. Government under National Stock Number 6505-01-387-1892. Manufacturer of record part number: NDC50228-0179-01.
Also searched as  6505-01-387-1892 · 6505013871892 · NIIN 013871892 · 01-387-1892 · FSC 6505 Drugs and Biologicals · CAGE 8NLP1 · NDC50228-0179-01 · NDC69097-0813-07 · NDC10135-0644-01 · NEUTRONTIN · NDC00071-0803-24
Nearby stock numbers  ·
Features
  • Gabapentin Capsules — FSC 6505
  • Administration: ORAL
  • Primary Container Type: BOTTLE
  • 3 manufacturer part numbers on file
  • Manufacturer of record: Sciegen Pharmaceuticals Inc
Identification
  • NSN: 6505-01-387-1892
  • NIIN: 013871892
  • FSC: 6505 — Drugs and Biologicals
  • FSG: 65 — Medical, Dental, and Veterinary Equipment
  • Primary part number: NDC50228-0179-01
  • Manufacturer: Sciegen Pharmaceuticals Inc
General Description

The Gabapentin Capsules, cataloged under National Stock Number 6505-01-387-1892, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sciegen Pharmaceuticals Inc. Government technical data includes 2 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: BT.

Technical Specifications
ParameterValue
NSN6505-01-387-1892
Primary Part NumberNDC50228-0179-01
Item NameGabapentin Capsules
FSC / FSG6505 / 65 — Drugs and Biologicals
ManufacturerSciegen Pharmaceuticals Inc
StatusACTIVE
AdministrationORAL
Primary Container TypeBOTTLE
Lifecycle & Compliance
Acquisition StatusACTIVE
DEMIL CodeDEMIL A — No Demilitarization Required
HazardPossible hazard — SDS may be required (DLA HMIC P)
Criticality CodeX
Unit of IssueBT
Cross-Reference Index
Part NumberManufacturer
NDC50228-0179-01 PRIMARY Sciegen Pharmaceuticals Inc (USA)
NDC69097-0813-07 Cipla Usa Inc (USA)
NDC10135-0644-01 PRIMARY Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I (USA)
Reference documents
ReferenceMeaning
NEUTRONTIN 5/1 Secondary reference
U.S. Government activity
NDC00071-0803-24 5/9 Secondary reference
Pfizer Pharmaceuticals
No interchangeability data on file.
Other items in FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073
6505-00-000-0073 · Item name not on file
6505-00-000-0110
6505-00-000-0110 · Item name not on file
6505-00-000-0134
6505-00-000-0134 · Item name not on file
6505-00-000-0135
6505-00-000-0135 · Item name not on file
6505-00-001-3344
6505-00-001-3344 · Item name not on file
6505-00-001-3345
FLUORESCEIN SODIUM AND BENOXINAT
6505-00-001-3346
6505-00-001-3346 · Item name not on file
6505-00-001-3347
6505-00-001-3347 · Item name not on file

Frequently Asked Questions

What is NSN 6505-01-387-1892?

NSN 6505-01-387-1892 is a Gabapentin Capsules, manufactured by Sciegen Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.

What part numbers are listed for NSN 6505-01-387-1892?

NSN 6505-01-387-1892 has 3 manufacturer part numbers on file: NDC50228-0179-01 (Sciegen Pharmaceuticals Inc), NDC69097-0813-07 (Cipla Usa Inc), NDC10135-0644-01 (Marlex Pharmaceuticals Inc Dba Marlex Pharmaceuticals I).

What are the specifications of NDC50228-0179-01?

Key specifications for NDC50228-0179-01: Administration: ORAL; Primary Container Type: BOTTLE; Special Features: 100 MG; 100 CAPSULES PER BOTTLE; Part Name Assigned by Controlling Agency: GABAPENTIN CAPSULES 100MG 100S BT. 2 specifications are documented in the U.S. Government catalog.

Is NSN 6505-01-387-1892 hazardous material?

Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.

Sources

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.

U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.

✓ Data cited from the U.S. Government catalog; commercial cross-references from OEM and certified industry sources.
PartsTable Design LLC · partstable.com